Clearance Summary
Active System; Avenue8 received FDA 510(k) clearance under submission number K241395, sponsored by Caerus Corporation. The device was reviewed via the Traditional premarket notification pathway and assigned to the Physical Medicine review panel. The statutory decision date of record is 2024-12-18.
- Submission: K241395
- Applicant / Sponsor: Caerus Corporation
- Clearance pathway: Traditional
- Review panel: Physical Medicine
- Device class: Class II
- Regulation citation: 21 CFR 890.5290
- Decision date: 2024-12-18
Classification & Regulation
This clearance is catalogued under FDA product code ILX and 21 CFR 890.5290, within the Physical Medicine review panel as a Class II device.